Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;15(3):223-8.
doi: 10.1007/s10198-013-0538-4. Epub 2013 Nov 23.

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

María-Isabel Farfan-Portet  1 , Sophie Gerkens, Isabelle Lepage-Nefkens, Irmgard Vinck, Frank Hulstaert
Affiliations
Review

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

María-Isabel Farfan-Portet et al. Eur J Health Econ. 2014 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Percentage of sales in DDD of biosimilars of total market (biosimilars, reference product and non-reference product). Source IMS data 2nd trimester 2011 [23]. *Only retail sector. DDD defined daily dose. Second-generation products not included
See this image and copyright information in PMC

References

    1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Off. J. Eur. Union 28 November 2001, L 311
    1. Rovira J, Espín J, García L, Olry de Labry A. The Impact of Biosimilars’ Entry in the EU Market. Granada: Andalusian School of Public Health; 2011.
    1. Borget I, Grivel T. Biosimilaires et facteurs medico-economiques. Bull. Cancer. 2010;97(5):589–595. - PubMed
    1. Grabowski H, Long G, Mortimer R. Implementation of the biosimilar pathway: economic and policy issues. Seton Hall Law Rev. 2011;41(2):511–557. - PubMed
    1. Moran N. Fractured European market undermines biosimilar launches. Nat. Biotechnol. 2008;26(1):5–6. doi: 10.1038/nbt0108-5. - DOI - PubMed

Substances

LinkOut - more resources